LSE:GNS (Genus plc)

About GNS

Genus applies science to animal breeding. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. It is a provider of bovine genetics and reproduction services, marketing in more than 70 countries.
  • Genus plc (LSE: GNS) Latest News

    Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
    Investing Articles

    Is it time I bought the huge 71% dip on this FTSE 250 growth stock?

    Our writer takes a look at one of the worst-performing growth stocks in the mid-cap index to see if it…

    Read more »

    Investing For Beginners

    Should I buy the current dogs of the FTSE 250?

    Jon Smith takes a look at the two worst-performing FTSE 250 stocks over the past month and weighs up whether…

    Read more »

    Genetic Techs with the text “Investing in Genetics Top UK Genetics Stocks in 2022” and The Motley Fool jester cap logo
    Page

    Investing in Genetics: Top UK Genetics Stocks of 2024

    Investing in genetics stocks is a risky endeavour. But given industry specialists have and continue to describe this space as…

    Read more »

    Investing Articles

    2 soaring small-cap growth stocks of 2020. Will their share prices fly in 2021?

    Many biotech and food companies fared well this year. Will these FTSE AIM All Share (INDEXFTSE: AXX) small-cap growth stocks…

    Read more »

    Investing Articles

    £1,000 to invest? I think buying this FTSE stock will make you money!

    Jabran Khan picks this FTSE 250 share as a great opportunity for you, especially on the back of impressive full-year…

    Read more »

    Investing Articles

    2 FTSE shares I’d buy in an ISA in April

    Here are two FTSE shares I think may be appropriate for a Stocks and Shares ISA when the annual allowance…

    Read more »

    Investing Articles

    Is the GSK share price primed to beat the FTSE 100?

    Could GlaxoSmithKline plc (LON: GSK) deliver stronger total returns than the FTSE 100 (INDEXFTSE: UKX)?

    Read more »

    Investing Articles

    2 stunning growth stocks you might regret not buying

    Roland Head breaks down the latest numbers from two mid-cap growth stocks.

    Read more »

    Investing Articles

    Two growth stocks that could make you a millionaire

    These two shares offer a potent mix of growth and value potential.

    Read more »

    Investing Articles

    Why I’d buy Tristel plc and avoid Genus plc after HY results

    Half-year results reveal two different stories with Tristel plc (LON: TSTL) and Genus plc (LON: GNS)

    Read more »

    Investing Articles

    Why I’d buy this small-cap over Genus plc despite today’s positive results

    This smaller company has better growth prospects than Genus plc (LON: GNS).

    Read more »

    Investing Articles

    Are these two hot biotechnology shares to buy today?

    Biotechnology is big business, but can you spot tomorrow's winners?

    Read more »